Andrea Lanese

582 total citations
28 papers, 371 citations indexed

About

Andrea Lanese is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Andrea Lanese has authored 28 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 8 papers in Surgery and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Andrea Lanese's work include Pancreatic and Hepatic Oncology Research (13 papers), Neuroendocrine Tumor Research Advances (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Andrea Lanese is often cited by papers focused on Pancreatic and Hepatic Oncology Research (13 papers), Neuroendocrine Tumor Research Advances (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Andrea Lanese collaborates with scholars based in Italy, Netherlands and India. Andrea Lanese's co-authors include Alessandro Bittoni, Kalliopi Andrikou, Stefano Cascinu, Matteo Santoni, Rossana Berardi, Luca Cantini, Federica Pecci, Francesca Muffatti, Stefano Partelli and Gianpaolo Balzano and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Andrea Lanese

27 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrea Lanese Italy	9	259	127	108	76	74	28	371
Philip Philip United States	9	361 1.4×	173 1.4×	153 1.4×	86 1.1×	143 1.9×	23	480
Toshiya Takeda Japan	9	245 0.9×	138 1.1×	52 0.5×	85 1.1×	164 2.2×	24	371
Jacob S. Ankeny United States	9	237 0.9×	75 0.6×	140 1.3×	47 0.6×	74 1.0×	23	365
Naomi Konishi Japan	9	199 0.8×	108 0.9×	40 0.4×	34 0.4×	123 1.7×	24	364
Manman Chen China	10	300 1.2×	235 1.9×	33 0.3×	34 0.4×	137 1.9×	17	495
Sabina Murgioni Italy	11	214 0.8×	145 1.1×	76 0.7×	28 0.4×	85 1.1×	38	361
Edwin A. Basak Netherlands	10	318 1.2×	92 0.7×	44 0.4×	44 0.6×	31 0.4×	18	403
Yueyun Chen China	9	170 0.7×	108 0.9×	57 0.5×	27 0.4×	64 0.9×	27	301
Cristiano Lanza Italy	10	126 0.5×	87 0.7×	69 0.6×	27 0.4×	85 1.1×	18	282

Countries citing papers authored by Andrea Lanese

Since Specialization

Citations

This map shows the geographic impact of Andrea Lanese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Lanese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Lanese more than expected).

Fields of papers citing papers by Andrea Lanese

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Lanese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Lanese. The network helps show where Andrea Lanese may publish in the future.

Co-authorship network of co-authors of Andrea Lanese

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Lanese. A scholar is included among the top collaborators of Andrea Lanese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Lanese. Andrea Lanese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Bittoni, Alessandro, Federica Pecci, Giulia Mentrasti, et al.. (2021). Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer. Annals of Translational Medicine. 9(3). 251–251. 31 indexed citations

2.

Cantini, Luca, Federica Pecci, Filippo Merloni, et al.. (2021). Old but gold: the role of drug combinations in improving response to immune check-point inhibitors in thoracic malignancies beyond NSCLC. SHILAP Revista de lepidopterología. 2 indexed citations

3.

Giampieri, Riccardo, Antonio Zizzi, Alessandro Bittoni, et al.. (2020). P-27 Retrospective observational analysis of p53 mutational status as a prognostic factor in TAS-102 treated metastatic colorectal cancer patients. Annals of Oncology. 31. S98–S98. 2 indexed citations

4.

Cantini, Luca, Federica Pecci, Daan P. Hurkmans, et al.. (2020). High-intensity statins are associated with improved clinical activity of PD-1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients. European Journal of Cancer. 144. 41–48. 83 indexed citations

5.

Bittoni, Alessandro, Federica Pecci, M. Della Giulia, et al.. (2020). P-117 Prognostic role of plasmatic exosomal and tissue caveolin-1 in metastatic pancreatic cancer patients. Annals of Oncology. 31. S128–S128. 2 indexed citations

6.

Giampieri, Riccardo, Elena Maccaroni, Federica Pecci, et al.. (2019). Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia. SHILAP Revista de lepidopterología. 8(1). 161–169. 1 indexed citations

7.

Bittoni, Alessandro, et al.. (2018). Prognostic factors in advanced pancreatic cancer patients receiving second-line chemotherapy: a single institution experience. Translational Cancer Research. 7(5). 1190–1198. 3 indexed citations

8.

Lanese, Andrea, Enrico Franceschi, & Alba A. Brandes. (2018). The Risk Assessment in Low-Grade Gliomas: An Analysis of the European Organization for Research and Treatment of Cancer (EORTC) and the Radiation Therapy Oncology Group (RTOG) criteria. Oncology and Therapy. 6(2). 105–108. 9 indexed citations

9.

Bittoni, Alessandro, et al.. (2018). Prognostic factors in advanced pancreatic cancer patients receiving second-line chemotherapy: a single institution experience. Translational Cancer Research. 7(5). 1190–1198. 4 indexed citations

10.

Cantini, Luca, Andrea Lanese, Daniele Nicolini, et al.. (2017). Are liver nested stromal epithelial tumors always low aggressive?. World Journal of Gastroenterology. 23(46). 8248–8255. 3 indexed citations

11.

Crippa, Stefano, Alessandro Bittoni, Stefano Partelli, et al.. (2016). Is there a role for surgical resection in patients with pancreatic cancer with liver metastases responding to chemotherapy?. European Journal of Surgical Oncology. 42(10). 1533–1539. 93 indexed citations

12.

Bittoni, Alessandro, Kalliopi Andrikou, Andrea Lanese, et al.. (2015). Trattamento del carcinoma del pancreas. Attualità e prospettive. Recenti Progressi in Medicina. 106(5). 208–16. 2 indexed citations

13.

Santoni, Matteo, Alessandro Conti, Kalliopi Andrikou, et al.. (2015). Risk of pruritus in cancer patients treated with biological therapies: A systematic review and meta-analysis of clinical trials. Critical Reviews in Oncology/Hematology. 96(2). 206–219. 13 indexed citations

14.

Santoni, Matteo, Kalliopi Andrikou, Alessandro Bittoni, et al.. (2015). Toll like receptors and pancreatic diseases: From a pathogenetic mechanism to a therapeutic target. Cancer Treatment Reviews. 41(7). 569–576. 48 indexed citations

15.

Andrikou, Kalliopi, Matteo Santoni, Francesco Piva, et al.. (2015). Lgr5 Expression, Cancer Stem Cells and Pancreatic Cancer: Results from Biological and Computational Analyses. Future Oncology. 11(7). 1037–1045. 8 indexed citations

16.

Lanese, Andrea, Alessandro Bittoni, Matteo Santoni, et al.. (2014). Clinical Outcome of Elderly (>70Y) Advanced Pancreatic Cancer Patients Receiving Chemotherapy. Annals of Oncology. 25. iv241–iv241. 1 indexed citations

17.

Lanese, Andrea, Alessandro Bittoni, Kalliopi Andrikou, et al.. (2014). Second-line treatment in patients with FOLFIRINOX-refractory pancreatic adenocarcinoma (PDAC): Doublets or single-agent chemotherapy?. Journal of Clinical Oncology. 32(15_suppl). e15186–e15186. 1 indexed citations

18.

Bittoni, Alessandro, et al.. (2014). Neoadjuvant Therapy in Pancreatic Cancer: An Emerging Strategy. Gastroenterology Research and Practice. 2014. 1–9. 22 indexed citations

19.

Santoni, Matteo, Alessandro Bittoni, Kalliopi Andrikou, et al.. (2014). Correlation of KRAS mutational state with the expression of the hedgehog pathway in patients with pancreatic ductal adenocarcinoma.. Journal of Clinical Oncology. 32(3_suppl). 227–227. 1 indexed citations

20.

Bittoni, Alessandro, Kalliopi Andrikou, Andrea Lanese, et al.. (2014). Single-Agent or Doublets As Second-Line Chemotherapy After Folfirinox in Patients with Locally Advanced or Metastatic Pancreatic Cancer. Annals of Oncology. 25. iv241–iv241. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact